Position in SRRK
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$105,646,609
+$16,047,852 QoQ
Shares Held
2,149,036
+5.7% QoQ
Ownership
1.79%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in SRRK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GEODE CAPITAL MANAGEMENT, LLC holds $18,580,924,343 across 526 Biotechnology names. SRRK ranks #39 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,139,621 | $2,741,586,360 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,607,732 | $2,014,838,051 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,660,385 | $880,241,584 | |
| 4 | INSM |
INSMED Inc
|
4,450,389 | $727,727,608 | |
| 5 | MRNA |
Moderna, Inc.
|
9,435,132 | $479,304,705 | |
| 6 | INCY |
Incyte Corp
|
4,703,184 | $442,663,677 | |
| 7 | RPRX |
Royalty Pharma plc
|
7,869,632 | $377,506,246 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
4,918,030 | $365,212,906 |
All Filings in SRRK
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $105,646,609 | 2,149,036 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $89,598,757 | 2,034,024 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $72,797,123 | 1,954,810 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $66,852,062 | 1,887,410 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $59,395,485 | 1,847,449 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $76,513,403 | 1,770,324 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $12,359,629 | 1,543,025 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $11,849,724 | 1,422,536 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $21,156,706 | 1,191,256 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $21,461,083 | 1,141,547 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $6,056,811 | 853,072 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $5,043,159 | 668,854 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $2,989,064 | 373,633 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $3,287,285 | 363,236 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $2,487,620 | 358,964 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,469,195 | 267,613 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $6,185,666 | 479,881 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $11,621,791 | 467,866 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $14,170,103 | 429,137 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $11,962,577 | 413,930 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $20,273,878 | 400,195 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $17,718,254 | 365,099 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $5,257,679 | 297,212 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $5,296,141 | 290,837 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $3,057,145 | 252,448 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||